News | September 17, 2024
Wacker collaborates with MinervaX for prophylactic vaccine targeting Group B streptococcus
Wacker Biotech will manufacture the active ingredients of MinervaX’s novel vaccine candidate
Wacker Biotech will manufacture the active ingredients of MinervaX’s novel vaccine candidate
Lasa Supergenerics Limited has been granted patent for an invention “Processes for Preparation and Purification of 5-Chloro-2-Nitroaniline
India's bio economy has experienced remarkable growth, skyrocketing from US $10 billion in 2014 to over $130 billion in 2024, with projections to reach $300 billion by 2030
Both the products are Gadolinium based Magnetic Resonance Imaging (MRI) contrast agents and will be the first set of contrast agent products in Zydus’ injectable portfolio for the US market
The acquisition is based on an enterprise value of Rs. 1,660 crore
TTP Group is a leading engineering firm specializing in biotech and pharmaceutical industry
New Phase II data show vast majority of patients experiencing no relapses or disability progression
Innovative product offerings to capitalise on emerging opportunities within and beyond the sexual wellness market
Mirabegron Extended-Release Tablets, 50 mg is a generic equivalent of Myrbetriq® Extended-Release Tablets, 50 mg of Astellas Pharma Global Development
Birajeev is a seasoned Supply Chain leader with an experience of 23 years
Subscribe To Our Newsletter & Stay Updated
